Henry Schein acquired RHCG, which had sales for the 12 months ended June 30, 2022, of $42 million, from Maurie and Bernard Stang, who wholly owned the company and retain a minority interest in Henry Schein’s ANZ dental business. Henry Schein expects the transaction to be neutral to 2023 diluted earnings per share when excluding amortization expenses and accretive thereafter. Financial terms were not disclosed.
Henry Schein acquired RHCG last year in May. https://www.businesswire.com/news/home/20230505005288/en/
The RHCG Med Cons Supply Solution is now being implemented in GP groups, day surgery sites, etc
- Forums
- ASX - By Stock
- Ann: Lumos Expands Distribution for FebriDx in AUS and NZ
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.9¢

Henry Schein acquired RHCG, which had sales for the 12 months...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.70M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.9¢ | $1.912K | 65.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 704125 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 704125 | 0.028 |
6 | 661954 | 0.027 |
2 | 443000 | 0.026 |
6 | 601153 | 0.025 |
1 | 1238229 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 150000 | 1 |
0.031 | 250309 | 3 |
0.032 | 51725 | 1 |
0.033 | 190000 | 1 |
0.034 | 189253 | 1 |
Last trade - 10.42am 20/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |